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Gene silencing due to epigenetic mechanisms shows evidence of significant contributions to
cancer development. We hypothesis that the genetic architecture based on retrotransposon
elements surrounding the transcription start site, plays an important role in the suppression and
promotion of DNA methylation. In our investigation we found a high rate of SINE and LINEs
retrotransposon elements near the transcription start site of unmethylated genes when
compared to methylated genes. The presence of these elements were positively associated with
promoter methylation, contrary to logical expectations, due to the malicious effects of
retrotransposon elements which insert themselves randomly into the genome causing possible
loss of gene function. In our genome wide analysis of human genes, results suggested that 22%
of the genes in cancer were predicted to be methylation-prone; in cancer these genes are
generally down-regulated and function in the development process. In summary, our
investigation validated our hypothesis and showed that these widespread genomic elements in
cancer are highly associated with promoter DNA methylation and may further participate in
influencing epigenetic regulation.
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INTRODUCTION

1.1 Epigenetics
Previously scientist have attributed a person phenotypic’s characteristics based
solely on the composition of the persons genomic DNA. It is through the genetic
composition and alterations that we have studied the neoplastic evolution and were
confounded to the idea that cancer was mainly a disease of genetics. Recently, the
study of external influences on the DNA has come to question this idea in favor of a
much larger complex mechanism known as epigenetics. Epigenetics was proposed by
Conrad Waddington in the 1940’s, and originally epigenetics focused on the study of
how genes and proteins bring phenotypes into being. Nowadays, it primarily studies the
mechanisms of how a cell becomes committed to particular functions and how those
functional states can be inherited in cell lineages [1]. In short it can be described as
heritable changes in gene expression that occur without changing a single DNA
sequence in the genome. A more concise scientific definition of epigenetics is from
Russel et. al: “The study of mitotically and/or meritoically heritable changes in gene
function that cannot be explained by changes in DNA sequence” [2].

Epigenetics has developed and grown in interest through the years to become a
hot topic in biology in cancer research, scientist have found that human tumors cells may
undergo major disruptions in the pattern of DNA methylation and histone modification [3].
“The aberrant epigenetic landscape of the cancer cell is characterized by a massive
genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor
genes, (loss of imprinting, chromatin modification), an altered histone code for critical
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genes and a global loss of monoacetylated and trimethylated histone H4 [4]” It is these
collective modifications that make up the human epigenome.

Scientist studying epigenetics have made the analogy between the genome and
epigenetics to the computer hardware and its software which runs the computer's
operation. As mentioned by Dolinoy et al, "The two most extensively studied epigenetic
mechanisms in mammals are methylation of cytosine at the carbon-5 position in CpG
dinucleotides and chromatin packaging of DNA via histone variants and posttranslational
histone modifications as well as subsequent nonhistone protein recruitment to specific
regions of DNA. [5]” Dolinoy et al. further sugests that, “Both chromatin condensation
and DNA methylation are generally associated with gene silencing. They are not
necessarily independent events, but may act together to alter gene transcription. [6] " In
addition, the aberrant epigenetic process can act as an alternative to DNA mutations to
shut down tumor-suppressor genes and can mediate genetic alternation by inactivating
DNA-repair genes ( e.g. DNA hypermethylation in tumorgenesis). These superimposed
epigenetic markers on the genome are areas of interest which may allow development of
diagnostic, treatment, and preventive models to change the instruction of such malicious
effects.
Through evolution the eukaryotic genome has continuously depleted itself from
the dinueclotide CpG [7]. In the normal mammalian genome we find that the remaining
CpG dinuclotides are methylated with a very high frequency, and this methylation in
mammals only occurs at the 5' cytosines to guanosines. It is suspected that this
remaining high frequency of CpG dinucleotide may help in the arrangement of chromatin
to repress the trancription in areas of repeated regions, such as transposons and Alu
sequences [8].
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1.2 CpG Islands

Although, targeted for depletion and present at lower than expected frequency,
clusters of CpG's do exist throughout the genome and are known as CpG Islands. They
are defined as regions of DNA with GC content above 0.5 UNIT and with a high
observed/expected frequency of the occurrence of CpG in a region approximately 1 kb
in length [9]. In the human genome, based on computation analysis, there are predicted
to be around 29,000 CpG islands [10, 11], DNA Methylation and epigenetic memory and
are usually found near the transcription start site in the promoter region of these genes.
Previous studies have estimates of CpG island and human gene association at around
60%, of which the vast majority are unmethylated in all tissue types and at all stages of
development [12]. Such finding and other literature support the belief that these regions
of DNA are 'protected' from methylation. Therefore, as stated by Baylin and Herman,
"this lack of methylation might be a prerequisite for active transcription [13]." They
presented two classic examples in which certain alleles of the imprinted autosomal gene
and multiple genes in the female inactive X-chromosome had been silenced through the
full methylation of the CpG Island in their promoter region. Classic examples such as
these and mounting literature have shown increasing support that the methylation of
CpG Island within promoter sequence may serve as markers in the prediction of gene
silencing.
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1.3 DNA Methylation Silencing

Transcriptional silencing of a gene by DNA methylation of a CpG island is
accomplished through the modification of chromatin that accompanies the base change,
in doing so it affects structure and preventing the transcription of the gene [14].

Fig. 1. “Epigenetic modifications of DNA. Euchromatic, transcriptionally-active DNA
becomes silenced through DNA methylation, binding of Methyl Binding Proteins (MBD)
and recruitment of Histone deacetylase (HDAC); this sequence of reactions lead to
histone deacetylation and chromatin condensation with formation of genes stably
silenced for the hindrance to the binding of transcription factors. DNA methylation and
MBD, by themselves, can also transiently modulate transcription factors binding” Figure
1 was reproduced with PERMISSION from [15].
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This transcriptional silencing of genes could then affect normal cell development,
or result in abnormal cell growth. Therefore, in addition to genetic mutations, epigenetic
silencing through DNA methylation could be viewed as an additional mechanism that
contributes to the disruption of cell production particularly by the silencing of tumor
suppressor genes.

For nearly all cases of human cancer, the silencing of an entire tumor suppressor
gene has been correctly shown to require Knudson's Two Hit Hypothesis [16]. To date
most attention has been centered on two pathways that promote the disabling of tumor
suppressor genes. The two pathways for disabling are intragenic mutations (i.e. loss of
hetorzygosity) and loss of chromosomal material (homozygous deletion). Yet, literature
also states transcriptional silencing may be caused through methylation of CpG Islands
in the promoter regions of genes. Many researchers armed with the knowledge that DNA
methylation patterns are abnormal in cancer cells, have suggested that this methylation
abnormality in the promoter regions of tumor suppressor genes might be associated to
human cancer [16, Figure 2].
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Fig. 2 “Knudson’s two-hit hypothesis revised. Two active alleles of a tumor suppressor
gene are indicated by the two green boxes shown at the top. The first step of gene
inactivation is shown as a localized mutation on the left or by transcriptional repression
by DNA methylation on the right. The second hit is shown by either LOH or
transcriptional silencing” Figure 2 was reproduced with permission from [16].

As explained in the figure above, both alleles in a tumor suppressor gene must
usually be disrupted and silenced in order to cause gene function loss [17] In Knudson's
model, a tumor suppressor gene in sporadic cancer may lose its function for example,
when an allele of a gene encounters a mutation (First Hit) and the other allele then
experiences a deletion (Second Hit). Similarly, function loss of a tumor suppressor gene
can be associated with abnormal methylation of the promoter CpG island. This occurs,
when an allele of tumor suppressor gene is methylated and second allele experience a
deletion. The loss of function through the mutation of both alleles is uncommon; it is
more often the case that both alleles of a gene are inactivated through the association of
6

DNA methylation. Additionally, Knudson's model describes tumor suppressor gene
inactivation in inherited cancer when an allele of a tumor suppressor gene suffers a
germ line mutation, and the second becomes inavtiavted because of a chromosomal
deletion. As described above, the second hit in inherited cancer may also be described
in the methylation of promoter regions with high a concentration of CpG's. As a result
there is an association which is exhibited in cancer when the loss of function is cause by
the aberrant methylation of a gene promoter region.

1.4 Retrotransposons

Sequences of DNA with the ability to move within the human genome of an
individual cell, are called transposons or transposable elements first discovered by
Barbara McClintock, for which she was later awarded a Nobel prize in 1983. The
process of movement for transposable elements between different locations is called
transposition. During transposition, transposable elements can affect the genome by
causing mutations and changing the number of bases in the DNA. These elements were
once known as jumping genes, due to their ability to move within the genome, and are
classic examples of what are known as mobile genetic elements.

There are several mobile genetic elements, and there are thus classified based on
their mechanism of transposition.
•

Retrotransposons are the first class (Class I) of these mobile genetic elements.
Their method of transposition is accomplished by first transcribing itself to RNA;
then using reverse transcriptase to reverse transcribe itself back to DNA; and
finally, re-inserting itself into a different position in the genome.
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•

The second class of mobile genetic elements (Class II) accomplishes
transposition using the enzyme transposase to "cut and paste" elements so that
they will directly move from one position to another within the genome.

A large portion of a eukaryote’s genome is made up transposable elements. Initially,
this large volume of what was thought to be useless material perplexed scientist, and
thus label "junk DNA [18]." Further studies have shown that these elements actually do
play important roles, amongst them development. They are indeed now viewed as useful
information to researchers, their role in DNA alterations have provided them with many
clues on inter workings inside the DNA of a living organism [18].

1.5 SINES AND LINES

As mentioned previously, once viewed as "junk DNA" transposons have gained
importance in recent years, specifically Class I, or retrotransposons. Within this class
two members of the family known as SINEs and LINEs exist. There names are
acronyms for Short Interspersed Nuclear Elements (SINEs) and Long Interspersed
Nuclear Elements (LINEs). They are particularly important because their presence can
lead to genetic instability [39]. Therefore, it is critical that retrotransposons remain silent,
and a key mechanism to accomplish this is DNA methylation.

In most eukaryotes these elements are the byproduct of an amplification process
which depends on the reverse transcription of an RNA intermediate [19]. The amount of
genome that these elements take up vary from species, from around 35% in humans [19]
to 60% and greater in specific plants such as maize [19]. Such large amounts of
amplification are a real threat to the host genome, since insertion of these elements into
8

new sites can bring about abnormal mutations [19]. In order to subdue such malicious
effects, the host cells counteract transposon mobility by a combining several strategies
to directly suppress one or several steps of these elements mobility process or on
targeting them away from genes [19].
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MATERIALS AND METHODS

2.1 Positional Weight Matrix

Positional Weight Matrices are considered the basis of motif finding algorithm
and are used as an algorithm to analyze and predict DNA binding sites. This common
analysis and prediction of DNA binding sites can be divided into two problems. Problem
one involves developing a representation of binding sites when given a collection of sites.
These representations are then used to locate new sequences and predict the location
where other binding sites occur. The second problem is that given a set of known
sequences containing binding sites for a common factors (e.g. retrotransposons
elements), but not knowing where the sites are located, one must identify the location of
the sites in each given sequence and representation for the specificity of the protein
[40]. In molecular biology, A major objective is to understand sequence-specific binding
of transcription factors. A Positional weight matrix may be viewed as a way to represent
a motif of interest. It specifies the probability of viewing a certain base of interest at each
index position of a motif.

2.2 Calculation of a Score to Predict Gene Promoter Predisposition to DNA
Methylation

The presence of SINE and LINE retrotransposons were annotated by dividing the
promoter sequence of 36 methylation-resistant and 36 methylation-prone genes from
into 10 bins downstream and 10 bins upstream of 1-kb sequence size for each gene’s
transcription start site (Figure 3A/4-A).
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Figure 3: SINE and LINE abundance score to predict gene predisposition
tomethylation in cancer.

Figure 3.” SINE and LINE abundance score to predict gene predisposition tomethylation
in cancer. (A) Annotation of SINE and LINE retrotransposons near the promoter
sequence of a representative methylation-prone gene (in this example, the CACNA1G
gene). The promoter sequencewas divided into 20 bins of 1-kb sequence each (10 bins
upstream and 10 bins downstreamof each gene TSS), and the presence of SINE and
LINE retrotransposons was annotated for each bin. Note that each element was
annotated to just one bin (the closest to TSS). The same procedure was followed for all
human genes with CpG islands overlapping or no more than 200 bp from their TSS. (B)
Example of a 20-letter acronym representing SINE retrotransposon abundance in a
11

collection of methylation-prone genes. (C) Counting of SINE presence (S) and absence
(G) in all human genes with a promoter CpG island (genome-wide) and the training set
ofmethylation-prone andmethylation-resistant genes. SINE abundance was converted to
standard log-odds ratios, as described in theMethods section, and the final substitution
matrix for SINE retrotransposons is presented (bottom table). The same calculation was
done for LINE retrotransposons. *Transcript variant coding for the P16INK4A protein.”
Figure 3 was reproduced with permission from [38].

Figure 4. “Graphic representation of the presence of (A) SINE and (B) LINE
retrotransposons in each 1-kb bin from transcription start site (TSS) of methylation-prone
and methylation-resistant genes.” Figure 4 was reproduced with permission from

[38].
12

“Each element was annotated to a single bin based on the start site of SINE or
LINE repeat, i.e. repeats belong to the bin in which their start sites fell. In doing so, we
created a 20-letter acronym representation for each gene based on the presence of
SINE and LINE. Two independent acronym sequences for SINE and LINE for each gene
were generated; locations free of the element were marked as G representing the
absence of that element (Figure 3B/ 4-B). Using this information we compared the
average abundance of LINE and SINE repeat elements per bin in methylation-resistant
and methylation-prone genes to their average abundance genomewide in the entire
collection of human promoter CpG islands, and interpreted the preference to
retrotransposon repeats to a score that distinguished two kinds of promoters. This score

is the standard log-odd ratio which is the sum over the bin score,

s i ,r = ln(

qi ,r
pr

)

where p,r is the background frequency for the repeat r , and qi,r is the frequency of
observing the repeat of type r for the i-th bin for the promoters known to be methylated.

To account for the low count and avoid taking logarithm of zero, qi,r is replaced

by Qi , r =

is type

Ci ,r + f r
N +1

derived from ‘pseudo-count’ where fr is the fraction of the repeat that

r : ∑ r f r = 1.

N is the total number of promoters with known methylation status; Ci,r is the number of
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repeat of type r in the i-th bin: ∑ r ci,r = N .

The final value for each letter in the 20-letter acronym represent the abundance of SINE
and LINE elements was calculated as the difference between its value in methylationprone and methylation-resistant genes (for example, , where Smp is the SINE standard
log-odd ratio in methylation-prone genes and Smr is the SINE standard log-odd ratio in
methylation-resistant genes). The calculation of the log-odd ratios for SINE elements is
illustrated in Figure 3-C” [38].
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RESULTS AND DISCUSSION

In order to identify sequence features that are associated with the predisposition of
DNA methylation in cancer, Dr. Marcos Estacio of the Department of Leukemia
compared the DNA sequence promoter region in the 4-kb region surrounding the
transcription start site of a training set. This set consisted of 36 methylation-resistant and
36 methylation-prone genes. The methylation analysis of the promoter region for the
genes used were accomplished through quantitative methods (bisulfate-PCR followed by
Cobra or pyrosequencing analysis) in nine cell lines. These genes, as well as the nine
cell lines and the peripheral blood mononuclear cell DNA from a healthy individual that
was used as a control, can be viewed in Table 1 and 2.
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Table 1: Training Set (reproduced with permission from [38]).
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Table 2: Methylation profile of the training set in nine cancer cell lines from
differenttissue origin (reproduced with permission from [38]).
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These particular 9 cancer lines were used because they have been identified as
heavily methylated in previous studies [20]. Therefore, non-methylated genes found in
these cell lines were unlikely to be found methylated elsewhere. Due to epigenetic
modifications targeting retrotransposons to suppress their mobilization [22], we asked
the question of whether methylation-prone genes have a different distribution of such
elements when compared to genes that were classified as methylation resistant. As
illustrated in Figure 5A, SINE and LINE repeats were approximately half as common in
methylation-prone as in methylation resistant genes. Annotations of other repeats were
analyzed but their distributions between methylation-resistant and methylation-prone
genes were not significantly different. Other features such as GC content, CpG Island
length, and CpG ratio have previously been shown to be associated with methylation
status in somatic tissues (Weber et. al, 2007), yet in our observation these variables
were not significantly different between methylation-prone and methylation-resistant
genes in cancer. (Fig 5B)
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Figure 5. “Distribution of repetitive elements in methylation-prone versus methylationresistant genes. (A) The abundance of repetitive elements of different classes was
determined for the 4-kb sequence window centered in the TSS of 36 methylationresistant (white) and 36methylation-prone (black) genes. Retrotranposons of the SINE
and LINE classes were found to be depleted in methylation-prone genes. *P < 0.02; **P
< 0.12 (Student’s t-test). (B) Average length, GC content, and CpG ratio of CpG islands
were not significantly different between methylation-prone and methylation-resistant
genes. Error bars represent SEM. (C) Abundance of SINE and LINE retrotransposons in
the 20-kb sequence window centered in the TSS of 36 methylation-prone and 36
methylation-resistant genes. The abundance of SINE and LINE retrotransposons
19

in all promoter CpGislands in the human genomeis shown in gray. Note that the
depletion of LINE retrotransposons is more significant in the _2-kb to +5-kb sequence
window.” Figure 5 was reproduced with permission from [38]

To investigate the effects of window size on the distribution of SINE and LINE
retrotransposons repeats between methylation-resistant and methylation-prone genes,
we increased our 4-kb window to a 20-kb region centered on the TSS and annotated for
every 1-kb non-overlapping window. This analysis identified a near depletion of SINE
repeats spanning the 20-kb region, the same did not hold for LINE repeats which only
showed a depletion occurring mainly in the -2kb to 5 kb window (Fig 5C). For every 1-kb
window, the log-odds score was calculated for SINE and LINE based on the full list of
human promoter CpG Island and their distribution in the training set. Taking the sum of
these scores in the 20-kb window enable us to measure the similarity in the distribution
of LINE and SINE retrotransposons in an individual gene promoter in contrast to the
average distribution of LINE and SINE in methylation-resistant and methylation-prone
genes (Fig. 4). Using this information, we can identify three groups in the training set: (i)
genes predicted as methylation-prone, i.e. genes depleted of both SINE and LINE, (ii)
genes predicted to be methylation-resistant, i.e. genes enriched both SINE and LINE,
and (iii) genes that showed enrichment of either SINE or LINE but not both. Comparing
our results with the methylation data for each individual of the 72 observed genes
showed that 19 of 23 (83%) genes predicted to be prone to methylation were indeed
hypermethylated in cancer, 23 and 25 (92%) genes predicted to be methylation resistant
were actually never or rarely hypermethylated in cancer (Fig. 6A). The 24 of 72 (34%)
genes showing a depletion of only one type of repeat represented a class of genes of
intermediate predisposition to methylation.

20

In order to validate our predictive method, we examined 68 methylation-resistant and
74 methylation prone genes with available promoter methylation data in cancer (Table 3
and 4) from a collection of tissues (Leukemia, colon, breast, and lung among others).
Table 3: Methylation-prone genes in cancer used as test set (reproduced with
permission from [38]).
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Table 4: Methylation-resistant genes in cancer used as test set (reproduced with
permission from [38]).
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As Fig. 6A displays, 92 % of genes predicted to be methylation resistant were not
methylated, and 83% of genes predicted to be methylation prone were in fact methylated
in cancer. Our observation also showed a 1:1 ratio of unmethylated to methylated genes
in our predicted methylation-intermediate group. A natural extension, to validate our
predictive method, was to test whether our model would hold in a large-scale analysis.
For this, we compared our three classes identified by MCAM analysis, in 32 primary
tissue and 28 cancer lines, consisting of more than 26000 probes representing around
6600 CpG island associated gene promoters. MCAM analysis is a sensitive and specific
micro method which is based on a selective amplification of methylated DNA after
restriction enzyme digestion [21, 23 (explain in more detail MCAM analysis). From our
MCAM analysis we observed that genes predicted as resistant to methylation had the
lowest values of measured promoter methylation. Genes predicted to be methylation
prone, however, displayed the highest average values of methylation (Fig. 6B and 6C).
This pattern was shown in 59 of 60 (98%) genes of the studied samples (Figure 7).
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Figure 6. “Prediction of gene predisposition and resistance to hypermethylation in
cancer. (A) SINE and LINE scores of the training set genes. The scores were calculated
according to the described log-odds ratio method for each gene and are represented as
horizontal bars (white bars, SINE score; black bars, LINE score). Methylation status
determined by bisulfite PCR methods is shown on the right. Genes with concordant
depletion of SINE and LINE retrotransposons (log-odds) were predominantly
methylation-prone, with the opposite found for genes with enrichment of both SINE and
24

LINE repeats. Discordant SINE and LINE scores likely represent a class of genes with
intermediate predisposition to methylation. *Transcript variant coding for the P16INK4A
protein. **Transcript variant coding for the P14ARF protein. Black rectangles represent
methylated genes; white rectangles represent unmethylated genes. (B) The predictive
method based on SINE and LINE retrotransposons abundance was applied to a test set
composed of 142 genes. The frequency of genes correctly classified according to their
DNA methylation status in cancer was 79% for methylation-resistant and 75% for
methylation-prone genes. These values were closely related to those found in the
training set (gray bars). (C ) Validation of the predictive method in a large set of cancer
cell lines and primary cancer tissues. Methylation status of more than 6600 autosomal
gene promoters was determined by MCAM. X chromosome genes were excluded from
this analysis due to their hemimethylated status in female samples. The measured DNA
methylation per tissue type was significantly higher in predicted methylation-prone genes
than in predicted methylation-resistant and methylation-intermediate genes. Methylation
is presented as the log2 ratio (cancer/control) of all oligonucleotide probes of a predicted
methylation status.” Figure 6 was reproduced with permission from [38]
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Figure 7. “Distribution of SINE, LINE and LTR repeats around the TSS of frequently
hypermethylated and unmethylated genes identified by MCAM analysis of 28 cancer cell
lines and 32 primary cancer tissues. The genome-wide distribution of these elements in
CpG island promoter genes is shown in gray.” Figure 7 was reproduced with permission
from [38].
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Lastly, if our model is correct, promoter CpG islands subjected to age-related
methylation, which accounts for a large fraction of promoter CGI methylation observed in
cancer [24], should also be depleted of SINE and LINE retrotransposons. To test this we
compared the distribution of SINE and LINE elements in the 20-kb region surrounding
the TSS of more than 6000 promoter CpG islands, that were identified as nonmethylated and methylated in young (3 months old) and old (35 months old) mice small
intestine tissue by MCAM analysis.
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Figure 8. Frequency of retroelements in methylation-prone and methylation-resistant
genes identified in mouse cancer models and old mice. (A) Depletion of SINE and LTR
but not LINE repeats near TSSmarks methylated promoter CpG islands in a mouse
model ofmyelodysplastic syndrome (MDS). Bone marrow samples of three NUP98HOXD13 transgene animals that developed MDS (Lin et al. 2005) were studied by
MCAM. Bone marrow samples from nontransgene animal of the same mouse strain was
used as control, and the methylation status of approximately 6000 CpG island promoter
genes was determined in the MCAM experiments. (B,C ) The same pattern of
retroelements depletion is observed in hypermethylated genes in CLL (Chen et al. 2009)
and intestinal cancer mouse models (Hahn et al. 2008). (D) Depletion of SINE, LINE,
and LTR repeats near TSS also marks age-related methylation promoter CpG islands.
Small intestine tissue harvested from young (3-mo-old) and old (35-mo-old) C57BL/6J
mice were used in MCAM experiments to identify age-related methylation. Figure 8 was
reproduced with permission from [38].

As displayed in Fig. 8, the results were similar to humans, just as human promoter
CpG islands predisposed to methylation in cancer, age-related methylated mouse
promoter CpG islands were also depleted of SINE and LINE repeats. Therefore, our
data suggest that predisposition to methylation in cancer and aging can be predicted
based on the distribution of such elements and that genes that show this predisposition
contain a common genome architecture marked by these elements.

The promising results of our predictive model lead us to apply it genome wide. Using
the NCBI build 36.1, we had 25,489 unique RefSeq genes, of these genes 16166 or
about 63.4% had a promoter CpG island. From these 16166 genes, 3664 or 22.7% were
indicated by our predictive model to be prone to methylation (methylation-prone), 7328
or 45.3% of genes were indicated to be moderately predisposed to methylation
(methylation-intermediate), and the rest of the 5714 or 32% of genes were predicted as
resistant to methylation (methylation-resistant). This description is illustrated by Fig. 9.
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Figure 9: “Genome-wide prediction of predisposition to DNA methylation in cancer. (A)
The pie chart shows the number of RefSeq genes with no CpG islands (dark gray) and
the number of predicted methylation-resistant (white), methylation-intermediate (light
gray), and methylation-prone (black) genes in promoter CpG island genes. (B) Gene
Ontology (GO) analysis of 1952 predicted methylation-prone and 2583
predictedmethylation-resistant genes for which functional information was available.
Horizontal bars represent the frequency of significant GO terms. (C ) Gene expression
analysis for 2822 promoter CpG island associated genes predicted methylation-prone
and 3651 predicted methylation-resistant genes in normal tissues. Expression values
were retrieved from the GNF database (Su et al. 2004) and Z-score normalized per
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tissue. Each bar represents the mean 6 SEM expression values in each tissue according
to their predicted methylation predisposition. (D) Gene expression analysis for 599
promoter CpG island associated genes predicted methylationprone and 996 predicted
methylation-resistant genes in 52 cancer cell lines. Expression values were retrieved
from a published work (Ross et al. 2000) and were analyzed as described in C. Only
genes present in the studied array platforms could be evaluated, resulting in a different
number of analyzed genes in each experiment.” Figure 9 was reproduced with
permission from [38].

Tables 5 and Table 6 also show the top 50 genes predicted by our model as prone
to methylation (methylation-prone) and resistant to methylation (methylation-resistant). In
order to check the biological implications of our model, we compared the mRNA
expression of predicted methylation-resistant and methylation-prone promoter CpG
island genes in 52 human cancer cell lines and 28 normal differential human tissue using
public microarray databases [25, 26].
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Table 5: Top 50 predicted Methylation-prone genes (reproduced with permission
from [38]).
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Table 6: Top 50 predicted Methylation-resistant genes (reproduced with permission
from [38]).

As illustrated in Fig. 10-B and 10-D, genes predicted as methylation-resistant
typically showed a lower expression in normal tissue than methylation-prone predicted
genes, as would be expected if the model was correct due to the fact that silencing is
correlated with hypermethylation of the promoter region. We also observed that genes
predicted as prone to methylation were down regulated in cancer cell lines when
compared to genes predicted as resistant to methylation (Fig. 10-C and 10-D). Therefore,
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the depletion of these elements near the TSS is identified as an independent predictor of
down regulation in cancer. The cause of down regulation is likely due to the promoter
CpG island methylation rather than the cell culture or even the cell type specific
differences in gene expression, since cancer cell lines previously shown to have the
highest degree of promoter CpG island methylation showed the lowest average
expression of predicted methylation-prone genes (Fig. 10-E).
In an interesting observation, we noted that non-CpG island promoter genes
depleted of SINE and LINE retrotransposons were found to be moderately down
regulated in cancer (Fig. 10-F).
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Figure 10.” Genome architecture influences on PcG protein binding in embryonic and
differentiated cells. (A) Frequency of predicted methylation groups among
hyperconserved domains. (B) Relative contribution of hyperconserved domains and
retrotransposon depletion in marking frequently methylated genes in cancer. MCAM data
from 32 primary tissues and 28 cancer cell lines were averaged to identify frequently
methylated genes. *Predicted status. (C ) Enrichment of H3K27me3 mark in predicted
methylation-prone genes in cancer (PC3, prostate; MCF7, breast) and normal mortalized
(PrEC, prostate epithelium) cell lines. H3K27me3 marking was measured by ChIP with
microarray hybridization (ChIP-chip) and is quantified as log2 ratio of pull-down signal
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over no antibody signal (Kondo et al. 2008). (D) Frequency of binding of SUZ12 and
EED (PcG proteins) in human embryonic stem cells to 2583 methylation-resistant, 3655
methylation-intermediate, and 1690 methylation-prone genes based on our predictive
model. Note that genes predicted methylation-prone (thus depleted for SINE and LINE
retrotransposons) are preferential targets of PcG proteins. (E ) Comparison of PcG
marking and our predictive model in identifying methylation-prone genes from our
training and first testing set. (F ) Average measuredmethylation of predicted methylationprone andmethylation-resistant genes in PcG marked genes. MCAM data from 32
primary tumors and 28 cancer cell lines were averaged per comparison group, and
methylation is presented as log2 ratio (cancer/control). The number of genes per
category is presented above each column.” Figure 10 was reproduced with permission
from [38].

Since the influence of non-CpG island promoter methylation on gene expression
is limited, this result prompted us to ask the question does the genome architecture
defined by SINE and LINE retrotransposons influence other epigenetic events besides
DNA methylation? To address this question, we did a comparison of the presence of
H3K27me3 between methylation resistant and methylation prone genes according to
chromatin imprinted microarray results for 8727 gene promoters in 3 cell lines: PC3, a
prostate cancer cell ; MCF7, a breast cancer cell line; and PrEC, an immortalized normal
prostate epithelial cell line [27].
Our work reveals a role for selected repetitive elements in determining polycomb
group proteins targeting, aberrant DNA methylation, and gene expression in cancer. A
paradoxical finding we noticed, was the depletion of the element SINE in genes prone to
methylation, finding was paradoxical due to the fact that the main family of these
elements (Alu family) were shown as nucleation centers in both plants and animals, and
these repeats have been hypothesized to spread DNA methylation in Cancer [32].
However, we must take into account, that these repetitive elements have shown the
opposite effect, such as working as insulator function [33, 34]. Despite this observation,
the precise mechanism by which these repeat elements contribute to protection is
unknown, it is likely that protection from de novo methylation is not directly mediated by
these elements, but instead by transcription factors such as CTCF [35] and SP1 [36]
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which contain euchromation/heterochromatin boundary activity. In such cases, genes
lacking the binding sites for such boundary proteins would be adversely affected by the
insertion of these elements near their promoters and therefore during evolution their
presence was counter selected. In fact, it has been displayed that these elements when
methylated are preferentially retained or inserted in gene-poor areas; this feature likely
came about through negative selection [37]. Aside of the actual mechanism by which
retrotransposons participate and are associated to the protection of de novo DNA
methylation in cancer; our research suggests that the genomic architecture has a greater
influence on disease and physiology than previously suspected.
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Conclusion and Future Direction

In recent years epigenetic modifications have been established as a key
molecular signature in the progression of tumorigenesis. Discoveries, such as
hypermethylation of the CpG island of certain tumor suppressor genes like BRAC1, link
DNA methylation to the established genetic understanding for disruption of critical
pathways in tumorigenesis. There range from apoptosis to DNA repair, cell cycle
regulation and cellular adhesion. Therefore, hypermethylation of the promoter is now
viewed as an established mechanism for gene inactivation.

A framework for

understanding the possible relationship between mutational events and altered DNA
methylation is presented. A case is made here to show how retrotransposable elements,
specifically LINEs and SINEs, are likely to function as key players a variety of toxicities,
including but not limited to carcinogenesis. As it is known methylation plays an important
role in supressing the gene activity of the inactive X chromosone in female mammals.
Methylation also plays a role in suppression of transposable elements, for example Alu
sequences within the gene. Speak on tumor supressor genes hypermethylation and and
how hey disrupt and contribute to the disruption of many cell path ways. The genes p15,
p14, and p16 on chromosone 9p21 are methylated in several cancers.

Future direction upon this project is to use other algorithm and methods such as
R-scan which is not restricted or is confined to a certain window. Development of a
threshold which would allow for better separation of methylation-prone genes and
methylation-resistant may create a more accurate using elements such as the
retrotransposons mentioned in this report. Although this study had some flaws, such as
threshold selection, predetermined windows, exclusion of other element (information)
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that may strengthen its predictive power, the Positional Weight Matrix showed evidence
of prediction with a high percentage value. Therefore, we found evidence that confirms
our belief that the genomic architecture marked by retrotransposon elements does in fact
play a part in the regulation of epigenetics. As for limitations of our research, to cite a
few, are that we can not model selection (some genes are tumor suppressor genes and
may be found methylated more frequently due their function in cancer, while oncogenes,
once silenced, may lead to cell elimination) and that we can only predict methylation
across multiple tissue, but not tissue-specific methylation. Therefore, we can better
predict genes that will be methylated in colon, breast or liver, but we cannot pick genes
that are exclusively methylated in one specific tissue. In short, our model is a
generalization of the microenvironment that allows for the de-novo methylation, but we
do not identify the triggers of the process. In conclusion, our findings help the field as a
whole by showing that not only selection and gene function are at work in gene silencing,
but also the gene microenvironment, and sheds light in the importance of genome
organization in diseases. Also, our data supports previous work from Vertino, where
some degree of concordance between repetitive elements and methylation was
mentioned. It refutes the idea that histone marking is the most crucial marker of
methylation-predisposition, as we show when comparing our method against H3K27me3.
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